摘要
背景:阿尔茨海默病(阿尔茨海默病)是一种以惊人的速度影响老年人的一种进行性神经退行性疾病。它已成为一个全球性的健康危机,给社会带来巨大的社会和经济负担。虽然AD无法治愈,重要的是要确定和实施预防策略,可能会延迟或防止症状,限制了负担,并提高这些患者的生活质量。充足的营养和体力活动两个潜在的生活方式改变的因素,他们在这一具有挑战性的疾病的预防和管理潜力引起了广泛的关注。在这篇综述中,我们讨论了体力活动和足够的营养的有益影响,以最大限度地减少AD患者的风险。 方法:研究问题最初是以结构化和显式的方式。使用广泛的科学数据库相关的研究进行了鉴定。其潜在的相关性是基于包含和排除的标准。选定的研究的质量进行更精确的质量评估,使用标准的工具。实施干预的详细描述,以及它如何不同于所接收的控制组进行了概述。干预对可测量的结果的研究样本的影响。 结果:纳入一百六十四篇文献,包括流行病学、纵向、横断面、干预和随机对照研究。文章着重介绍了各种营养膳食补充剂对人类认知能力以及与AD和轻度认知障碍(MCI)动物的影响。此外,体育锻炼对广告的动物模型中的认知功能的影响进行了概述。
关键词: 阿尔茨海默病,表观遗传学,营养,身体活动。
Current Alzheimer Research
Title:Can Diet and Physical Activity Limit Alzheimer's Disease Risk?
Volume: 14 Issue: 1
Author(s): Shraddha D. Rege, Thangiah Geetha, Tom L. Broderick, Jeganathan Ramesh Babu
Affiliation:
关键词: 阿尔茨海默病,表观遗传学,营养,身体活动。
摘要: Background: Alzheimer's disease (AD) is a progressive neurodegenerative disease affecting elderly individuals at an alarming rate. It has become a global health crisis imposing tremendous social and economic burden on society. Although there is no cure for AD, it is important to identify and implement preventive strategies that may delay or prevent the symptoms, limit the burden, and improve the quality of life of those afflicted. Adequate nutrition and physical activity are the two potential lifestyle modifiable factors that have gained considerable interest for their potential in the prevention or management of this challenging disease. In this review, we discuss the beneficial effects of physical activity and adequate nutrition on minimizing the risk of developing AD.
Methods: The research question was initially formulated in a structured and explicit way. Relevant studies were identified using a wide range of scientific databases. Their potential relevance was based on the criteria for inclusion and exclusion. The quality of selected studies was subjected to a more precise quality assessment using standard tools. A detailed description of the implemented intervention and how it differed from what the control group received was outlined. The effects of intervention on measurable outcomes for the study sample were applied. Results: One hundred and sixty-four references were included in the review comprising of epidemiological, longitudinal, cross-sectional, intervention and randomized controlled studies. This review highlighted the effect of various nutrient diet supplements on cognitive performance in humans as well as animals with AD and mild cognitive impairment (MCI). Moreover, the effect of physical exercise on the cognitive function in animal models with AD was outlined. Conclusion: The findings of this review highlight the therapeutic potential of combination of nutritionally adequate diet and physical activity in preventing or delaying the symptoms associated with AD pathology.Export Options
About this article
Cite this article as:
Shraddha D. Rege, Thangiah Geetha, Tom L. Broderick, Jeganathan Ramesh Babu , Can Diet and Physical Activity Limit Alzheimer's Disease Risk?, Current Alzheimer Research 2017; 14 (1) . https://dx.doi.org/10.2174/1567205013666160314145700
DOI https://dx.doi.org/10.2174/1567205013666160314145700 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pituitary Adenylate Cyclase Activating Polypeptide: A Potential Neuroprotective Peptide
Current Pharmaceutical Design Preventive and Protective Roles of Dietary Nrf2 Activators Against Central Nervous System Diseases
CNS & Neurological Disorders - Drug Targets Potential Benefits of Glitazones for Cancer and Vascular Disease
Current Drug Therapy Developing Histone Deacetylase Inhibitors as Anti-Cancer Therapeutics
Current Medicinal Chemistry Prognostic and Predictive Biomarkers in Cancer
Current Cancer Drug Targets Nicotinic Acetylcholine Receptor Interaction with β -Amyloid: Molecular, Cellular, and Physiological Consequences
Current Alzheimer Research The Neuronal Cytoskeleton as a Potential Therapeutical Target in Neurodegenerative Diseases and Schizophrenia
Current Drug Targets - CNS & Neurological Disorders 1, 2-Benzisoxazole: A Privileged Structure with a Potential for Polypharmacology
Current Pharmaceutical Design CXCR4 Receptor as a Promising Target for Oncolytic Drugs
Mini-Reviews in Medicinal Chemistry Neurodevelopment in Schizophrenia: The Role of the Wnt Pathways
Current Neuropharmacology Molecular Targeted Magnetic Resonance Imaging of Human Colorectal Carcinoma (LoVo) Cells Using Novel Superparamagnetic Iron Oxide- Loaded Nanovesicles: In Vitro and in vivo Studies
Current Cancer Drug Targets Chemokine Receptors as Targets for Cancer Therapy
Current Pharmaceutical Design Ketamine Induces Toxicity in Human Neurons Differentiated from Embryonic Stem Cells via Mitochondrial Apoptosis Pathway
Current Drug Safety Peptides as Carrier for Tumor Diagnosis and Treatment
Current Medicinal Chemistry - Anti-Cancer Agents Drug Targets from Genetics: Alpha-Synuclein
CNS & Neurological Disorders - Drug Targets Silybin and Silymarin - New and Emerging Applications in Medicine
Current Medicinal Chemistry Peptides for In Vivo Target-Specific Cancer Imaging
Mini-Reviews in Medicinal Chemistry Recent Advances in Characterizing Natural Products that Regulate Autophagy
Anti-Cancer Agents in Medicinal Chemistry The Wnt Pathway in Mood Disorders
Current Neuropharmacology Tumor-Targeting Peptides: Ligands for Molecular Imaging and Therapy
Anti-Cancer Agents in Medicinal Chemistry